Higher Risk Myelodysplastic Syndromes in Patients with Well-Controlled HIV Infection: Clinical Features, Treatment, and Outcome.

about

Evidence for persistence of the SHIV reservoir early after MHC haploidentical hematopoietic stem cell transplantation

P2860

Q58561116-A6E23684-DB58-480D-9C8D-589407BBB47C

P2860

Higher Risk Myelodysplastic Syndromes in Patients with Well-Controlled HIV Infection: Clinical Features, Treatment, and Outcome.

Item

http://www.wikidata.org/entity/Q38283075

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Higher Risk Myelodysplastic Sy ...... tures, Treatment, and Outcome.

@en

type

Item

label

Higher Risk Myelodysplastic Sy ...... tures, Treatment, and Outcome.

@en

prefLabel

Higher Risk Myelodysplastic Sy ...... tures, Treatment, and Outcome.

@en

P1476

Higher Risk Myelodysplastic Sy ...... tures, Treatment, and Outcome.

@en

P2093

Bradley T Williamson

http://www.w3.org/2001/XMLSchema#string

Heather A Leitch

http://www.w3.org/2001/XMLSchema#string

P2860

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia

International scoring system for evaluating prognosis in myelodysplastic syndromes

5-azacytidine and 5-azadeoxycytidine inhibit human immunodeficiency virus type 1 replication in vitro

Frequent pathway mutations of splicing machinery in myelodysplasia

Toxicity and response criteria of the Eastern Cooperative Oncology Group

Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.

Persistence of side population cells with high drug efflux capacity in pancreatic cancer.

Myelodysplasia associated with acquired immunodeficiency syndrome.

Antiretroviral activity of 5-azacytidine during treatment of a HTLV-1 positive myelodysplastic syndrome with autoimmune manifestations.

P304

8502641

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2016/8502641

http://www.w3.org/2001/XMLSchema#string

P478

2016

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26904323

http://www.w3.org/2001/XMLSchema#string

P932

4745308

http://www.w3.org/2001/XMLSchema#string

Higher Risk Myelodysplastic Syndromes in Patients with Well-Controlled HIV Infection: Clinical Features, Treatment, and Outcome.

about

P2860

P2860

Higher Risk Myelodysplastic Syndromes in Patients with Well-Controlled HIV Infection: Clinical Features, Treatment, and Outcome.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932